Gastroesophageal Junction Adenocarcinoma Clinical Trials in San Antonio, Texas
4 studies are recruiting for gastroesophageal junction adenocarcinoma in San Antonio, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
The purpose of the study is to explore the safety and effects of the study drug (PF-08046876) in people diagnosed with advanced cancer of the bladder, lung, head and neck, esophagus, or pancreas. PF-08046876 is an investigational anticancer therapy called an 'antibody drug conjugate' or 'ADC'. ADCs…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- NEXT Oncology, San Antonio, Texas
- Locations
- 31 in total
- Run by
- Pfizer
-
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the earl…
- Stage
- Not phased
- Ages
- 40 to 75
- Site
- Audie L Murphy VA Hospital, San Antonio, Texas
- Locations
- 745 in total
- Run by
- Alliance for Clinical Trials in Oncology
-
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
This clinical trial is studying advanced solid tumors. Solid tumors are cancers that start in a part of your body like your lungs or liver instead of your blood. Once tumors have grown bigger in one place but haven't spread, they're called locally advanced. If your cancer has spread to other parts …
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- South Texas Accelerated Research Therapeutics, LLC, San Antonio, Texas
- Locations
- 48 in total
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
-
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
This trial will look at a drug called sigvotatug vedotin (SGN-B6A) alone and with pembrolizumab, with or without chemotherapy, to find out whether it is safe for people who have solid tumors. It will study sigvotatug vedotin to find out what its side effects are. A side effect is anything the drug …
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- South Texas Accelerated Research Therapeutics, LLC, San Antonio, Texas
- Locations
- 158 in total
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.